Enliven Therapeutics (ELVN) Q4 2019 Earnings

11MarExpected
Q3 2019
Q4 2019
-0.68
-0.45
-0.23
0

Details

Expected EPS
0
Actual EPS
-0.68
Surprise EPS
-0.68
Surprise Percent
+∞%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.68 per share for Q4 2019.

0 Comments

Share your thoughts